…ocial distancing, implemented as public health measures to slow COVID-19 transmission, had a major impact on the epidemiology of viral i…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 74 of 2459…hort 1 has 43 patients all with HLA A2 receiving ipilimumab and nivolumab with 10 doses of intra-muscular SCIB1 over 24-months. Cohort 3 …
…patients with advanced-stage cancers treated with PD-L1 ICIs at Providence Health System and West Cancer Center, including 87 metastatic renal cell carc…
…Int J Mol Med. 2021;48:214.Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin P…
… relief.Conclusions As a potential chemotherapy companion drug, AK135 potently targets IL-1RAP to block IL-1/IL-33/IL-36-driven infla…
…oval This study was conducted with IACUC approval (#51068) from Fred Hutch Cancer Center.Abstract 238 Figure 1Abstract 238 Figure 2…
…ale sex, Black race, advanced age, hypertension, diabetes, lung cancer, and combination therapy were independently associated with hig…
…cyte count (ALC) identifies a subgroup unlikely to benefit from pembrolizumab.Methods We performed a single-center retrospective study of adu…
…xperienced CD8 T cells in i.c. and s.c. SB28 compared to ICB or NOX-A12 monotherapy. Additionally, the combination treatment increased …
…mary objective of dose escalation is to determine MTD and RP2D. Pembrolizumab (200 mg IV) will be given with micvo at escalating doses starti…
…d regulations of the University of Virginia and approved by the University of Virginia Animal Care and Use Committee.Abstract 656 Figure 1Subtotal T-F…